先健科技(01302.HK):元心科技(深圳)获增资至3000万元 引入深圳心元加速项目研发进程
格隆汇9月16日丨先健科技(01302.HK)宣布,于2019年9月16日,公司全资附属先健深圳与深圳心元签订了股东合作协议及增资协议。根据增资协议,先健深圳与深圳心元将分别按照70%和30%的约定增资比例向合资公司元心科技(深圳)首期增加注册资本至人民币3000万元整。
于后续若干里程碑事件达成时限及合资公司的业务取得一定进展后,双方将根据股东协议分别按照70%和30%的比例持续向合资公司增资,增资不超过人民币6146万元及人民币2634万元整;同时双方就有关合资公司的营运、管理及业务发展等达成一致意见。
合约方投入的资金将主要用于合资公司的运营,及后续视乎业务发展情况购买公司持续发展所需资产。增资协议和股东协议乃基于加速项目的研发进展、拓展铁基项目相关的产品组合以及吸收人才之目的而书就及达成。
公告显示,合资公司注册成立为公司的全资子公司,在合约方按照增资协议共同增资前由先健深圳单独出资人民币953万元作初步注册资本。合资公司的主要业务包括研究、开发、制造及销售医用生物可吸收金属材料产品及提供相关技术服务。
深圳心元由张德元博士(为公司过去12个月的董事)最终拥有36.67%权益及项目团队(为集团雇员)最终拥有63.33%权益(均为独立于公司及公司的关连人士以外的第三方)。据此,张博士于合资公司的最终间接持股比例约为11%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.